COLL vs NOC · P/E 17, rev $181.9M vs P/E 17, rev $41.95B
Collegium Pharmaceutical Inc (COLL) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the COLL and NOC stock pages for the full models.
Not investment advice.